Ebola and Ethical Considerations

Released: 14-Aug-2014 1:00 PM EDT
Source Newsroom: University of Louisville
Expert Available
Add to Favorites
Contact Information

Available for logged-in reporters only

Newswise — Should health professionals use experimental treatments on humans? Most would say “no” but when it comes to Ebola, the answer gets a bit more complicated. University of Louisville professor Mark Rothstein can address the ethical implications of using the drug ZMapp and who should get it. He can also discuss other ethical issues such as quarantine and isolation, travel restrictions and allocation of resources. Rothstein is director of the Bioethics Institute at the U of L School of Medicine and can be reached at 502-852-4982 or at mark.rothstein@louisville.edu.

Promote your organization’s experts with Expert Pitch.
Reporters: follow @Expert_Pitch to receive instant updates via Twitter
Looking for a different expert? Reporters can submit an
Expert Query.